Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients

Abstract Heart failure (HF), a major cause of morbidity and mortality worldwide, is prevalent among individuals with H-type hypertension, which is marked by high blood pressure and elevated homocysteine. The Triglyceride-Glucose (TyG) index, a surrogate for insulin resistance, may predict HF in this...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengwen Xu, Xisheng Yan, Dongsheng Li, Xiaodong Huang
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-89211-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862496725827584
author Zhengwen Xu
Xisheng Yan
Dongsheng Li
Xiaodong Huang
author_facet Zhengwen Xu
Xisheng Yan
Dongsheng Li
Xiaodong Huang
author_sort Zhengwen Xu
collection DOAJ
description Abstract Heart failure (HF), a major cause of morbidity and mortality worldwide, is prevalent among individuals with H-type hypertension, which is marked by high blood pressure and elevated homocysteine. The Triglyceride-Glucose (TyG) index, a surrogate for insulin resistance, may predict HF in this group, though its specific role requires clarification. This study explores the TyG index’s relationship with HF incidence in H-type hypertension patients. A retrospective cohort study was conducted on 1200 H-type hypertension patients at Wuhan Third Hospital from January 2021 to December 2023. The TyG index was determined using fasting triglyceride and glucose levels. We utilized multivariate Cox regression, adjusting for age, sex, BMI, and lifestyle, to analyze the TyG index’s impact on HF. Of the 1,200 patients studied, 254 (21.2%) developed HF over a median follow-up of 24 months. Higher TyG index values significantly correlated with increased HF risk, with each unit rise boosting HF incidence by 45%. Patients in the highest TyG tertile had a notably higher HF incidence (HR 1.45, 95% CI 1.29–1.63, p < 0.001). This association was stronger in diabetic patients compared to non-diabetics. The TyG index showed high predictive accuracy (AUC = 0.78) with good sensitivity (70.9%) and specificity (72.3%) at a cut-off of 8.88. Elevated TyG index significantly predicts higher HF risk in H-type hypertension patients, especially among diabetics. Integrating the TyG index into routine evaluations could improve management and outcomes for high-risk individuals, offering an economical early risk stratification tool.
format Article
id doaj-art-8d6d65cd16bd48d1b8e21d41493ce8c8
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8d6d65cd16bd48d1b8e21d41493ce8c82025-02-09T12:32:01ZengNature PortfolioScientific Reports2045-23222025-02-0115111010.1038/s41598-025-89211-wTriglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patientsZhengwen Xu0Xisheng Yan1Dongsheng Li2Xiaodong Huang3Department of Cardiology, Wuhan Third Hospital & Tongren Hospital of Wuhan UniversityDepartment of Cardiology, Wuhan Third Hospital & Tongren Hospital of Wuhan UniversityDepartment of Cardiology, Wuhan Third Hospital & Tongren Hospital of Wuhan UniversityDepartment of Cardiology, Wuhan Third Hospital & Tongren Hospital of Wuhan UniversityAbstract Heart failure (HF), a major cause of morbidity and mortality worldwide, is prevalent among individuals with H-type hypertension, which is marked by high blood pressure and elevated homocysteine. The Triglyceride-Glucose (TyG) index, a surrogate for insulin resistance, may predict HF in this group, though its specific role requires clarification. This study explores the TyG index’s relationship with HF incidence in H-type hypertension patients. A retrospective cohort study was conducted on 1200 H-type hypertension patients at Wuhan Third Hospital from January 2021 to December 2023. The TyG index was determined using fasting triglyceride and glucose levels. We utilized multivariate Cox regression, adjusting for age, sex, BMI, and lifestyle, to analyze the TyG index’s impact on HF. Of the 1,200 patients studied, 254 (21.2%) developed HF over a median follow-up of 24 months. Higher TyG index values significantly correlated with increased HF risk, with each unit rise boosting HF incidence by 45%. Patients in the highest TyG tertile had a notably higher HF incidence (HR 1.45, 95% CI 1.29–1.63, p < 0.001). This association was stronger in diabetic patients compared to non-diabetics. The TyG index showed high predictive accuracy (AUC = 0.78) with good sensitivity (70.9%) and specificity (72.3%) at a cut-off of 8.88. Elevated TyG index significantly predicts higher HF risk in H-type hypertension patients, especially among diabetics. Integrating the TyG index into routine evaluations could improve management and outcomes for high-risk individuals, offering an economical early risk stratification tool.https://doi.org/10.1038/s41598-025-89211-wHeart failureDiabetesTriglyceride glucose indexH-type hypertension
spellingShingle Zhengwen Xu
Xisheng Yan
Dongsheng Li
Xiaodong Huang
Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients
Scientific Reports
Heart failure
Diabetes
Triglyceride glucose index
H-type hypertension
title Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients
title_full Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients
title_fullStr Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients
title_full_unstemmed Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients
title_short Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients
title_sort triglyceride glucose index as a biomarker for heart failure risk in h type hypertension patients
topic Heart failure
Diabetes
Triglyceride glucose index
H-type hypertension
url https://doi.org/10.1038/s41598-025-89211-w
work_keys_str_mv AT zhengwenxu triglycerideglucoseindexasabiomarkerforheartfailureriskinhtypehypertensionpatients
AT xishengyan triglycerideglucoseindexasabiomarkerforheartfailureriskinhtypehypertensionpatients
AT dongshengli triglycerideglucoseindexasabiomarkerforheartfailureriskinhtypehypertensionpatients
AT xiaodonghuang triglycerideglucoseindexasabiomarkerforheartfailureriskinhtypehypertensionpatients